Cargando…

Temozolomide and Capecitabine Treatment for an Aggressive Somatotroph Pituitary Tumor: A Case Report and Literature Review

Aggressive somatotroph pituitary tumor that causes acromegaly is extremely rare and resists conventional treatments such as multiple surgeries, radiotherapies, and various types of somatostatin analogs. Here, we propose a novel treatment option for these rare cases by discussing our case and reviewi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ishida, Atsushi, Shichi, Hiroki, Fukuoka, Hidenori, Shiramizu, Hideki, Inoshita, Naoko, Yamada, Shozo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9197190/ https://www.ncbi.nlm.nih.gov/pubmed/35712496 http://dx.doi.org/10.3389/fonc.2022.916982

Ejemplares similares

Proteogenomic landscape and clinical characterization of GH-producing pituitary adenomas/somatotroph pituitary neuroendocrine tumors
por: Yamato, Azusa, et al.
Publicado: (2022)

MON-406 Two Cases of Aggressive Corticotroph Pituitary Tumors Treated with Capecitabine and Temozolomide
por: Tateno, Tae, et al.
Publicado: (2019)

Tumor Shrinkage by Metyrapone in Cushing Disease Exhibiting Glucocorticoid-Induced Positive Feedback
por: Tsujimoto, Yasutaka, et al.
Publicado: (2021)

Apoplexy in sellar metastasis from papillary thyroid cancer: A case report and literature review
por: Hirayama, Masahiro, et al.
Publicado: (2022)

Touch imprint cytology is useful for the intraoperative pathological diagnosis of PitNETs’ surgical margins
por: Tanabe, Noriaki, et al.
Publicado: (2023)

Temozolomide in aggressive pituitary adenomas and carcinomas
por: Ortiz, Leon D., et al.
Publicado: (2012)

A Case of Nonfunctioning Pituitary Carcinoma That Responded to Temozolomide Treatment
por: Morokuma, Haruko, et al.
Publicado: (2012)

Aggressive Pituitary Macroadenoma Treated With Capecitabine and Temozolomide Chemotherapy Combination in a Patient With Nelson’s Syndrome: A Case Report
por: Mirallas, Oriol, et al.
Publicado: (2021)

MON-435 The Responsiveness To Ddavp Test Predicts Usp8 Mutation In Patients With Cushing's Disease
por: Shichi, Hiroki, et al.
Publicado: (2019)

Silent Corticotroph and Somatotroph Double Pituitary Adenoma: A Case Report and Review of Literature
por: Pecorari, Isabella L., et al.
Publicado: (2022)

Tumour-infiltrating cytotoxic T lymphocytes in somatotroph pituitary neuroendocrine tumours
por: Iacovazzo, Donato, et al.
Publicado: (2019)

Pituitary Somatotroph Adenoma-derived Exosomes: Characterization of Nonhormonal Actions
por: Zhou, Cuiqi, et al.
Publicado: (2021)

MON-905 A Case of Cushing’s Disease with Glucocorticoid Positive-Feedback
por: Shichi, Hiroki, et al.
Publicado: (2020)

Hemostasis through Extended Transsphenoidal Route for Subarachnoid Hemorrhage after Conventional Transsphenoidal Surgery for a Pituitary Adenoma
por: YOSHIMOTO, Haruko, et al.
Publicado: (2021)

Case Report: Cytologic Description of Somatotroph Pituitary Adenoma in a Cat
por: Alonso, Flavio H., et al.
Publicado: (2022)

Follicle-stimulating Hormone-secreting Pituitary Adenoma Accompanied by Painful Thyroiditis
por: Ichijo, Masashi, et al.
Publicado: (2019)

Corticosterone induces growth hormone expression in pituitary somatotrophs during goose embryonic development
por: YU, Jianning, et al.
Publicado: (2018)

Expression of Prolactin Receptor mRNA in Lactotrophs and Somatotrophs of the Chicken Anterior Pituitary Gland
por: Kaneda, Hiromi, et al.
Publicado: (2018)

Pituitary Somatotroph Adenoma Cell-Derived Exosomes: Characterization of Novel Non-Hormonal Functions
por: Zhou, Cuiqi, et al.
Publicado: (2021)

Lipotoxicity suppresses the synthesis of growth hormone in pituitary somatotrophs via endoplasmic reticulum stress
por: Gong, Ying, et al.
Publicado: (2021)

Efficacy and safety of temozolomide in the treatment of aggressive pituitary neuroendocrine tumours in Spain
por: Lamas, Cristina, et al.
Publicado: (2023)

Capecitabine and Temozolomide in Neuroendocrine Tumor of Unknown Primary
por: Chauhan, Aman, et al.
Publicado: (2018)

Somatotrophs and lactotrophs: an immunohistochemical study of Gallus domesticus pituitary gland at different stages of induced moult
por: Sandhu, M.A., et al.
Publicado: (2010)

Clinical, hormonal and pathomorphological markers of somatotroph pituitary neuroendocrine tumors predicting the treatment outcome in acromegaly
por: Tomasik, Agnieszka, et al.
Publicado: (2022)

ODP311 Giant-versus Macroadenomas: Does Size Really Matter in Pituitary Somatotroph Adenomas?
por: Sendur, Suleyman Nahit, et al.
Publicado: (2022)

The effect of endoscopic transsphenoidal somatotroph tumors resection on pituitary hormones: systematic review and meta-analysis
por: Nie, Ding, et al.
Publicado: (2023)

SUN-272 Significant Response to Temozolomide in Two Aggressively Growing Pituitary Adenomas
por: Kreitschmann-Andermahr, Ilonka, et al.
Publicado: (2020)

Early Initiation of Temozolomide Therapy May Improve Response in Aggressive Pituitary Adenomas
por: Das, Liza, et al.
Publicado: (2021)

Clinically silent somatotroph adenomas are common
por: Wade, Alisha N, et al.
Publicado: (2011)

Clinicopathological Features of Growth Hormone-Producing Pituitary Adenomas in 242 Acromegaly Patients: Classification according to Hormone Production and Cytokeratin Distribution
por: Mori, Ryosuke, et al.
Publicado: (2013)

Treatment of Aggressive Prolactin-Secreting Pituitary Adenomas with Adjuvant Temozolomide Chemotherapy: A Review
por: Moisi, Marc, et al.
Publicado: (2016)

Clinical Efficacy of Temozolomide and Its Predictors in Aggressive Pituitary Tumors and Pituitary Carcinomas: A Systematic Review and Meta-Analysis
por: Luo, Mei, et al.
Publicado: (2021)

Neoadjuvant Chemotherapy with Capecitabine and Temozolomide for Unresectable Pancreatic Neuroendocrine Tumor
por: Devata, Sumana, et al.
Publicado: (2012)

Outcomes of Capecitabine and Temozolomide (CAPTEM) in Advanced Neuroendocrine Neoplasms (NENs)
por: Thomas, Katharine, et al.
Publicado: (2020)

Treatment of ampullary neuroendocrine tumor by Capecitabine (Xeloda®) and Temozolomide (Temodal®)
por: Noorali, Sima, et al.
Publicado: (2021)

Efficacy of Capecitabine and Temozolomide in Small Bowel (Midgut) Neuroendocrine Tumors
por: Al-Toubah, Taymeyah, et al.
Publicado: (2022)

Temozolomide Therapy for Aggressive Pituitary Tumors: Results in a Small Series of Patients from Argentina
por: Bruno, Oscar D., et al.
Publicado: (2015)

Somatotroph Tumors and the Epigenetic Status of the GNAS Locus
por: Romanet, Pauline, et al.
Publicado: (2021)

Capecitabine-Associated Loss of Fingerprints: Report of Capecitabine-Induced Adermatoglyphia in Two Women with Breast Cancer and Review of Acquired Dermatoglyphic Absence in Oncology Patients Treated with Capecitabine
por: Cohen, Philip R
Publicado: (2017)

A Pituitary Carcinoma Patient With Cerebrospinal Fluid Dissemination Showing a Good Response to Temozolomide Combined With Whole-Brain and Spinal Cord Radiotherapy: A Case Report and Literature Review
por: Du, Peng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3ihjt8ida1pto677t8j5fdsfim